Debbie Zittema

Vasopressin, Copeptin, and Renal Concentrating Capacity in Patients with Autosomal Dominant Polycystic Kidney Disease without Renal Impairment

Debbie Zittema, Wendy E. Boertien, André P. van Beek et al. · Clinical Journal of the American Society of Nephrology · 2012 · 117 citations

Copeptin, a surrogate marker for vasopressin, is associated with kidney function decline in subjects with autosomal dominant polycystic kidney disease

Wendy E. Boertien, Esther Meijer, Debbie Zittema et al. · Nephrology Dialysis Transplantation · 2012 · 79 citations · Full text

Kidney Function and Plasma Copeptin Levels in Healthy Kidney Donors and Autosomal Dominant Polycystic Kidney Disease Patients

Debbie Zittema, Else van den Berg, Esther Meijer et al. · Clinical Journal of the American Society of Nephrology · 2014 · 50 citations · Full text

The Effect of Renal Function and Hemodialysis Treatment on Plasma Vasopressin and Copeptin Levels

Esmée M. Ettema, Judith E. Heida, Niek F. Casteleijn et al. · Kidney International Reports · 2017 · 31 citations · Full text

Use of the Urine-to-Plasma Urea Ratio to Predict ADPKD Progression

Judith E. Heida, Ron T. Gansevoort, A. Lianne Messchendorp et al. · Clinical Journal of the American Society of Nephrology · 2021 · 29 citations · Full text